These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8201209)

  • 1. Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure.
    Hughes RD; Zhang L; Tsubouchi H; Daikuhara Y; Williams R
    J Hepatol; 1994 Jan; 20(1):106-11. PubMed ID: 8201209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure.
    Miwa Y; Harrison PM; Farzaneh F; Langley PG; Williams R; Hughes RD
    J Hepatol; 1997 Nov; 27(5):780-8. PubMed ID: 9382963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss and recovery of liver regeneration in rats with fulminant hepatic failure.
    Eguchi S; Lilja H; Hewitt WR; Middleton Y; Demetriou AA; Rozga J
    J Surg Res; 1997 Oct; 72(2):112-22. PubMed ID: 9356231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.
    Pereira LM; Langley PG; Hayllar KM; Tredger JM; Williams R
    Gut; 1992 Jan; 33(1):98-102. PubMed ID: 1740285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay.
    Tsubouchi H; Niitani Y; Hirono S; Nakayama H; Gohda E; Arakaki N; Sakiyama O; Takahashi K; Kimoto M; Kawakami S
    Hepatology; 1991 Jan; 13(1):1-5. PubMed ID: 1824837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of serum human hepatocyte growth factor levels in patients with hepatic failure.
    Tomiya T; Nagoshi S; Fujiwara K
    Hepatology; 1992 Jan; 15(1):1-4. PubMed ID: 1530786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure.
    Tsubouchi H; Hirono S; Gohda E; Nakayama H; Takahashi K; Sakiyama O; Miyazaki H; Sugihara J; Tomita E; Muto Y
    Hepatology; 1989 Jun; 9(6):875-81. PubMed ID: 2523850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor and plasminogen activation in fulminant hepatic failure.
    Pernambuco JR; Hughes RD; Langley PG; Izumi S; Williams R
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):511-5. PubMed ID: 7841306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom.
    Lee WS; McKiernan P; Kelly DA
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):575-81. PubMed ID: 15861019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of the acute phase response in fulminant hepatic failure.
    Izumi S; Hughes RD; Langley PG; Pernambuco JR; Williams R
    Gut; 1994 Jul; 35(7):982-6. PubMed ID: 8063228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of hepatocyte growth factor receptor (c-met) gene expression in fulminant hepatic failure livers before transplantation.
    Ljubimova JY; Petrovic LM; Arkadopoulos N; Blanc P; Geller SA; Demetriou AA
    Dig Dis Sci; 1997 Aug; 42(8):1675-80. PubMed ID: 9286233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure.
    Panos MZ; Anderson JV; Forbes A; Payne N; Slater JD; Rees L; Williams R
    Gut; 1991 Jan; 32(1):85-9. PubMed ID: 1825077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality.
    Acharya SK; Dasarathy S; Irshad M
    J Hepatol; 1995 Jul; 23(1):8-13. PubMed ID: 8530814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model.
    Ho DW; Fan ST; To J; Woo YH; Zhang Z; Lau C; Wong J
    Gut; 2002 Jun; 50(6):869-76. PubMed ID: 12010892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human hepatocyte growth factor in blood of patients with fulminant hepatic failure. Basic aspects.
    Gohda E; Tsubouchi H; Nakayama H; Hirono S; Arakaki N; Yamamoto I; Hashimoto S; Daikuhara Y
    Dig Dis Sci; 1991 Jun; 36(6):785-90. PubMed ID: 1827762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant Wilson's disease in children: appraisal of a critical diagnosis.
    Tissières P; Chevret L; Debray D; Devictor D
    Pediatr Crit Care Med; 2003 Jul; 4(3):338-43. PubMed ID: 12831417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure.
    Izumi S; Langley PG; Wendon J; Ellis AJ; Pernambuco RB; Hughes RD; Williams R
    Hepatology; 1996 Jun; 23(6):1507-11. PubMed ID: 8675171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma inhibitory activity against tumour necrosis factor in fulminant hepatic failure.
    Keane HM; Sheron N; Goka J; Hughes RD; Williams R
    Clin Sci (Lond); 1996 Jan; 90(1):77-80. PubMed ID: 8697709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed encephalopathy in fulminant hepatic failure in the pediatric population and the role of liver transplantation.
    Rivera-Penera T; Moreno J; Skaff C; McDiarmid S; Vargas J; Ament ME
    J Pediatr Gastroenterol Nutr; 1997 Feb; 24(2):128-34. PubMed ID: 9106097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the molecular forms of fibronectin in fulminant hepatic failure.
    Almasio PL; Hughes RD; Williams R
    Hepatology; 1986; 6(6):1340-5. PubMed ID: 3098666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.